Yanli Xu
- Infectious Diseases top 0.5%
- Radiology, Nuclear Medicine and Imaging top 2%
- Oncology top 5%
- Neurology top 2%
- Pulmonary and Respiratory Medicine top 5%
- Topics
- COVID-19 Clinical Research Studies (10 papers)SARS-CoV-2 and COVID-19 Research (9 papers)SARS-CoV-2 detection and testing (5 papers)
- Partner nations
- ChinaUnited StatesCzechia
In The Last Decade
Yanli Xu
17 papers receiving 3.7k citations
Hit Papers
Peers
Comparison fields: 5 of 141
- Infectious Diseases 2.5k
- Radiology, Nuclear Medicine and Imaging 849
- Oncology 622
- Neurology 513
- Pulmonary and Respiratory Medicine 500
Countries citing papers authored by Yanli Xu
This map shows the geographic impact of Yanli Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanli Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanli Xu more than expected).
Fields of papers citing papers by Yanli Xu
This network shows the impact of papers produced by Yanli Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanli Xu. The network helps show where Yanli Xu may publish in the future.
Co-authorship network of co-authors of Yanli Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Yanli Xu. A scholar is included among the top collaborators of Yanli Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanli Xu. Yanli Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 5 | |
| 5 | 0 | |
| 6 | 11 | |
| 7 | 2 | |
| 8 | 14 | |
| 9 | 6 | |
| 10 | 9 | |
| 11 | 56 | |
| 12 | 12 | |
| 13 | 8 | |
| 14 | 161 | |
| 15 | 15 | |
| 16 | Detection of SARS-CoV-2 in Different Types of Clinical Specimensbreakdown → | 3448 |
| 17 | 3 | |
| 18 | 2 | |
| 19 | 1 | |
| 20 | [A clinical analysis of 33 cases of H1N1 influenza A]. | 3 |
About Yanli Xu
Yanli Xu is a scholar working on Infectious Diseases, Neurology and Small Animals, having authored 20 papers that have together received 3.8k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (10 papers), SARS-CoV-2 and COVID-19 Research (9 papers) and SARS-CoV-2 detection and testing (5 papers). The work is most often cited by research in Infectious Diseases (2.5k citations), General Dentistry (116 citations) and Modeling and Simulation (212 citations). Yanli Xu has collaborated with scholars based in China, United States and Czechia. Frequent co-authors include Wen‐Ching Wang, Ruqin Gao, Kai Han, Guizhen Wu, Wenjie Tan, Roujian Lu, Guiju Gao, Meiling Chen, Fujie Zhang and Yangzi Song. Their work appears in journals such as JAMA, Annals of Internal Medicine and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.